LACTB and melanoma: In melanoma, delivery of LACTB via gene therapy showed promising results in both in vitro and in vivo models, where LACTB successfully inhibited cell cycle progression, induced G2/M cell cycle arrest, and enhanced apoptosis, further establishing its role in cell cycle regulation (Figure 3) [23].